Front. Aging
Frontiers in Aging
Front. Aging
2673-6217
Frontiers Media S.A.
1483030
10.3389/fragi.2024.1483030
Aging
Correction
Expression of concern: Simufilam suppresses overactive mTOR and restores its sensitivity to insulin in Alzheimer’s disease patient lymphocytes
Frontiers Editorial Office
10.3389/fragi.2024.1483030
Frontiers Editorial Office
*
Approved by: Frontiers Editorial Office, Frontiers Media SA, Switzerland
*Correspondence: Frontiers Editorial Office, research.integrity@frontiersin.org
22
08
2024
2024
5
1483030
19
08
2024
19
08
2024
Copyright © 2024 Frontiers Editorial Office.
2024
Frontiers Editorial Office
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
An Expression of Concern on Simufilam suppresses overactive mTOR and restores its sensitivity to insulin in Alzheimer’s disease patient lymphocytes by Wang H-Y, Pei Z, Lee K-C, Nikolov B, Doehner T, Puente J, Friedmann N and Burns LH (2023). Front. Aging 4:1175601. doi: 10.3389/fragi.2023.1175601
section-at-acceptance
Molecular Mechanisms of Aging
With this notice, Frontiers states its awareness of concerns regarding the images for “Simufilam suppresses overactive mTOR and restores its sensitivity to insulin in Alzheimer’s disease patient lymphocytes” published on the 29th of June 2023. An investigation is currently being conducted in accordance with COPE guidelines. This notice will be updated as soon as the investigation is complete.